青春期前高级别非肌层浸润性尿路上皮癌的TURBT与膀胱内BCG治疗
本文报告一名10岁女性高级别非肌层浸润性膀胱尿路上皮癌患者,接受经尿道膀胱肿瘤电切术(TURBT)及膀胱内卡介苗(BCG)治疗。因患儿年龄小,当地成人机构无法提供BCG,作者借鉴成人经验制定儿童医院首次BCG输注方案。患者完成7个周期诱导与维持BCG,无复发且副作用轻微。
要点
- 儿童高级别非肌层浸润性膀胱尿路上皮癌罕见且无既定指南。
- 10岁女性患儿经TURBT及膀胱内BCG成功治疗。
- 借鉴成人经验制定儿童医院BCG输注方案,7周期无复发。
核心结论
- 儿童高级别非肌层浸润性膀胱尿路上皮癌可经TURBT联合膀胱内BCG治疗,本例7周期无复发且副作用轻微。
研究设计与样本
- 单例病例报告:一名10岁女性患儿,经内镜诊断高级别非肌层浸润性尿路上皮癌。
主要发现
- 患儿成功完成7个周期诱导与维持BCG治疗,无疾病复发,副作用轻微。
临床怎么用
- 儿童病例可借鉴成人机构经验制定BCG输注方案,在儿童医院实施。
局限性
- 单例报告,儿童人群罕见,无既定指南,结论推广受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
High-grade urothelial carcinoma of the bladder is rare in the pediatric population with no established guidelines for management. We treated a single female patient, 10 years of age, who was found to have high-grade, nonmuscle invasive urothelial carcinoma endoscopically and with intravesical bacille calmette guerin (BCG). Given the child's age, no local adult institution could provide BCG therapy. Utilizing the experience of the local adult institutions, we developed a comprehensive protocol for first-time delivery of BCG at a free-standing children's hospital. The patient has undergone successful induction and maintenance BCG for 7 cycles without disease recurrence and minimal side effects.
引用
- Rague JT, Lee RS. Management of High-grade, Nonmuscle Invasive Urothelial Carcinoma in a Prepubertal Patient With TURBT and Intravesical BCG. Urology. 2018. PMID: 30366046. doi:10.1016/j.urology.2018.10.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。